4,163
Views
90
CrossRef citations to date
0
Altmetric
REVIEWS

TLR Cross-talk Confers Specificity to Innate Immunity

, , &
Pages 443-453 | Accepted 20 Apr 2014, Published online: 09 Jun 2014

REFERENCES

  • Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010;327:291–295.
  • Eisen HN, Chakraborty AK. Evolving concepts of specificity in immune reactions. Proc Natl Acad Sci U S A 2010;107:22373–22380.
  • Wooldridge L, Ekeruche-Makinde J, van den Berg HA, A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012;287:1168–1177.
  • Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004;430:257–263.
  • Kurtz J. Specific memory within innate immune systems. Trends Immunol 2005;26:186–192.
  • Vivier E, Malissen B. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat Immunol 2005;6:17–21.
  • Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991–1045.
  • Fontana MF, Vance RE. Two signal models in innate immunity. Immunol Rev 2011;243:26–39.
  • Arstila TP, Casrouge A, Baron V, A direct estimate of the human alphabeta T cell receptor diversity. Science 1999;286:958–961.
  • Underhill DM. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods. Immunol Rev 2007;219:75–87.
  • Delaloye J, Roger T, Steiner-Tardivel QG, Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009;5:e1000480.
  • Slater L, Bartlett NW, Haas JJ, Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010;6:e1001178.
  • Ferwerda G, Kullberg BJ, de Jong DJ, Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol 2007;82:1011–1018.
  • Negishi H, Yanai H, Nakajima A, Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat Immunol 2012;13:659–666.
  • Bender VA, Bender KJ, Brasier DJ, Feldman DE. Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J Neurosci 2006;26:4166–4177.
  • Netea MG, Nold-Petry CA, Nold MF, Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009;113:2324–2335.
  • Lindsay RW, Darrah PA, Quinn KM, CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 2010;185:1513–1521.
  • Ku CL, von Bernuth H, Picard C, Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007;204:2407–2422.
  • Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 2011;34:629–636.
  • Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99:2694–2702.
  • Dennehy KM, Ferwerda G, Faro-Trindade I, Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 2008;38: 500–506.
  • Dennehy KM, Willment JA, Williams DL, Brown GD. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 2009;39:1379–1386.
  • Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007;7:454–465.
  • Rothlin CV, Ghosh S, Zuniga EI, TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007;131:1124–1136.
  • Meyer-Wentrup F, Cambi A, Joosten B, DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol 2009;85:518–525.
  • Johnson AC, Li X, Pearlman E. MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase. J Biol Chem 2008;283:3988–3996.
  • Siednienko J, Gajanayake T, Fitzgerald KA, Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-beta and RANTES production. J Immunol 2011;186:2514–2522.
  • Crozat K, Vivier E, Dalod M. Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunol Rev 2009;227:129–149.
  • Ishii KJ, Koyama S, Nakagawa A, Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008;3:352–363.
  • Mukhopadhyay S, Herre J, Brown GD, Gordon S. The potential for Toll-like receptors to collaborate with other innate immune receptors. Immunology 2004;112:521–530.
  • Netea MG, Van der Meer JW, Sutmuller RP, From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 2005;49:3991–3996.
  • Agrawal S, Agrawal A, Doughty B, Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003;171:4984–4989.
  • Sato S, Nomura F, Kawai T, Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000;165:7096–7101.
  • De Nardo D, De Nardo CM, Nguyen T, et al. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol 2009;183:8110–8118.
  • Theiner G, Rossner S, Dalpke A, TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol Immunol 2008;45:244–252.
  • Napolitani G, Rinaldi A, Bertoni F, Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005;6: 769–776.
  • Zhu Q, Egelston C, Vivekanandhan A, Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci U S A 2008;105:16260–16265.
  • Zhu Q, Egelston C, Gagnon S, Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 2010;120:607–616.
  • Piao W, Song C, Chen H, Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009;86:863–875.
  • de Vos AF, Pater JM, van den Pangaart PS, In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009;183:533–542.
  • Wenink MH, Santegoets KC, Broen JC, TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. J Immunol 2009;183:6960–6970.
  • Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A 2006;103:17343–17348.
  • Bagchi A, Herrup EA, Warren HS, MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007;178:1164–1171.
  • Ouyang X, Negishi H, Takeda R, Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007;354:1045–1051.
  • Arpaia N, Godec J, Lau L, TLR signaling is required for salmonella typhimurium virulence. Cell 2011;144:675–688.
  • Gautier G, Humbert M, Deauvieau F, A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005;201:1435–1446.
  • Malissen B, Ewbank JJ. ‘TaiLoRing’ the response of dendritic cells to pathogens. Nat Immunol 2005;6:749–750.
  • Krummen M, Balkow S, Shen L, Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J Leukoc Biol 2010;88:189–199.
  • Rathinam Vijay AK, Vanaja Sivapriya K, Waggoner L, TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria. Cell 2012;150:606–619.
  • Petricevic B, Wessner B, Sachet M, CL097, a TLR7/8 ligand, inhibits TLR-4–dependent activation of IRAK-M and BCL-3 expression. Shock 2009;32:484–490.
  • Lang R, Hammer M, Mages J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006;177:7497–7504.
  • Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007;6:391–403.
  • Tross D, Petrenko L, Klaschik S, Zhu Q, Klinman DM. Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. Mol Immunol 2009;46:2557–2564.
  • Tan S, Lin B, Liu Q, The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages. Immunol Cell Biol 2013;91:377–387.
  • Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses. Cell Immunol 2007;247:72–84.
  • Mäkelä SM, Strengell M, Pietilä TE, Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009;85:664–672.
  • Hirata N, Yanagawa Y, Ebihara T, Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. Mol Immunol 2008;45:2734–2742.